Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Oct 27, 2024; 16(10): 3224-3238
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3224
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3224
Figure 5 Decision curve analysis curves of progression-free survival.
A: 1 year; B: 2 years; C: 3 years.
- Citation: Wang YC, Feng L, Wang GP, Yu PJ, Guo C, Cai BJ, Song Y, Pan T, Lin BH, Li YD, Xiao JJ. Comparison of efficacy and safety of nab-paclitaxel and oxaliplatin + S-1 and standard S-1 and oxaliplatin chemotherapy regimens for treatment of gastric cancer. World J Gastrointest Surg 2024; 16(10): 3224-3238
- URL: https://www.wjgnet.com/1948-9366/full/v16/i10/3224.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i10.3224